NCT07901699

Active Not Recruiting

Resumption of Anticoagulation After Major Gastrointestinal B...

Società Italiana di Medicina Interna Source

Compare

Other study identifiers

Sponsor study identifier

RAFTING-GIB

Study Type

observational

Estimated enrollment

650

Locations

1 country

Sites

1

Timeline

Study Start

January 5, 2024

Actual (reported)

Primary Completion

November 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Study Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Brief Summary

Prospective multicenter observational study on resumption of anticoagulant therapy after major gastrointestinal bleeding in patients with atrial fibrillation

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: active not recruiting
Estimated enrollment: 650 participants
Study completion date: December 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 5, 2024
Actual (reported)
First Submitted
October 22, 2026
Actual (reported)
First Posted
October 28, 2026
Actual (reported)
Primary Completion
November 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 2026
Estimated
Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated: October 28, 2026
Status Verified: October 2026
Last Update Submitted: October 22, 2026

Conditions

Atrial Fibrillation (AF)Gastrointestinal Bleeding

Keywords

Atrial Fibrillation (AF)AnticogulantVKIDOACMajor Gastointestinal Bleeding (MGIB)

Outcome Measures

Primary Outcomes (1)

Major gastrointestinal bleeding as assessed by central independent adjudication committee
Recurrence of Major GIB at 90 days as assessed by central independent adjudication committee
90 days

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Consecutive patients fullfilling inclusion criteria and with no exclusion criterion

You may qualify if:

Adults ≥ 18 years old

Sponsors & Collaborators

Società Italiana di Medicina Interna
Otherlead

Study Sites (1)

Università degli Studi di Perugia

Perugia, PG, 06132, Italy

MeSH Terms

Conditions

Atrial FibrillationGastrointestinal Hemorrhage

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsGastrointestinal DiseasesDigestive System DiseasesHemorrhage

Study Officials

Cecilia Becattini, MD, PhD
University Of Perugia
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

October 22, 2026

First Posted

October 28, 2026

Study Start

January 5, 2024

Actual (reported)

Primary Completion

November 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

NCT06216769

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

Not ApplicableRecruiting

NCT06354777

REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry

Active Not Recruiting

NCT06174506

The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers

Unknown

NCT07129564

Stepwise Strategy for Treatment of Atrialfibrillation Substrate Study

Recruiting

NCT05086991

AIHEMAF - P "An Innovative Healthcare Model for AF Patients"

Completed

NCT05845034

A New Theory of Electrophysiological Mechanism of Atrial Fibrillation

Not ApplicableUnknown

confirmed atrial fibrillation on treatment with VKAs or DOACs;

Signed informed consent;

You may not qualify if:

Indication for anticoagulant treatment different from atrial fibrillation
Refusal of informed consent.

Contact the study team to confirm eligibility.

Study Completion

December 2026

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Last Updated

October 28, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing: Will share
Shared Documents: STUDY PROTOCOL

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT07901699
Data provider: ClinicalTrials.gov
Source updated: 2026-10-28
Normalization version: ctgov-2

Open registry record

Source retrieved: 2026-10-29 23:02:25 UTC

Locations

IT(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations